Skip to main content

Find Clinical Trials

Home
Conditions
Double Expressor Lymphoma

Clinical trial condition

Double Expressor Lymphoma

Explore clinical trials studying Double Expressor Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Double Expressor Lymphoma trial results

Not Yet Recruiting

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

NCT07511114

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Double Expressor Lymphoma, +6 more
Locations: No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai Shanghai, China

View Trial Details

Not Yet Recruiting

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

NCT06652152

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Double Expressor Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

NCT04164368

Conditions: Double Expressor Lymphoma
Locations: 270 Dongan Road, Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Active, Not Recruiting

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

NCT04479267

Conditions: Diffuse Large B-cell Lymphoma, Double Expressor Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details